null - FindTrial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224518

Enrollment

240

Registered

2019-01-11

Start date

2019-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : INN of investigational material : Difelikefalin Therapeutic category code : 119 Other agents affecting central nervous system Dosage and Administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
efficacy	—

Secondary

Measure	Time frame
efficacy	—

Countries

Japan

Contacts

Public ContactYoshitaka Shimizu

rinsyousiken@pharm.kissei.co.jp+81-3-5684-3533

Outcome results